MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

NCT02764281 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK-T-Cell Lymphoma, Nasal Type

Interventions

DRUG: MEDA
PROCEDURE: Auto-HSCT

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine